Xaga Surgical, a Helsingborg-based medical technology firm, has recently completed a SEK 8M investment round. Key investors included Almi Invest, contributing SEK 3M, along with participation from Smile Inject Capital and other private investors. The funding aims to support Xaga's journey towards commercialisation and FDA approval for its advanced medical needles that significantly reduce infection risks and improve cancer diagnostics. Founded in 2016, the company addresses pressing health issues caused by unsafe needle practices, potentially safeguarding millions and reducing economic burdens associated with needle-related infections.
Our investment in Xaga Surgical is part of our commitment to supporting life science companies in commercialising their innovations to contribute to global health.
The global market for medical needles faces significant challenges, with over 50 million people annually at risk of health issues related to needle infections, costing an estimated $80B.
Collection
[
|
...
]